Literature DB >> 11134977

Effects of daily oral administration of quercetin chalcone and modified citrus pectin on implanted colon-25 tumor growth in Balb-c mice.

A Hayashi1, A C Gillen, J R Lott.   

Abstract

The health benefits of fruits and vegetables have been the subject of numerous investigations over many years. Two natural substances, quercetin (a flavonoid) and citrus pectin (a polysaccharide found in the cell wall of plants) are of particular interest to cancer researchers. Two modified versions of these substances - quercetin chalcone (QC) and a pH-modified citrus pectin (MCP) - are the focus of this study. Previous research has confirmed that quercetin exhibits antitumor properties, likely due to immune stimulation, free radical scavenging, alteration of the mitotic cycle in tumor cells, gene expression modification, anti-angiogenesis activity, or apoptosis induction, or a combination of these effects. MCP has inhibited metastases in animal studies of prostate cancer and melanoma. To date, no study has demonstrated a reduction in solid tumor growth with MCP, and there is no research into the antitumor effect of QC. This study examines the effects of MCP and QC on the size and weight of colon-25 tumors implanted in balb-c mice. Fifty mice were orally administered either 1 ml distilled water (controls), low-dose QC (0.8 mg/ml), high-dose QC (1.6 mg/ml), low-dose MCP (0. 8 mg/ml) or high-dose MCP (1.6 mg/ml) on a daily basis, beginning the first day of tumor palpation (usually eight days post-implantation). A significant reduction in tumor size was noted at day 20 in all groups compared to controls. The groups given low-dose QC and MCP had a 29-percent (NS) and 38-percent (p<0.02) decrease in size, respectively. The high-dose groups had an even more impressive reduction in size; 65 percent in the QC group and 70 percent in the mice given MCP (both p<0.001). This is the first evidence that MCP can reduce the growth of solid primary tumors, and the first research showing QC has antitumor activity. Additional research on these substances and their effect on human cancers is warranted.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11134977

Source DB:  PubMed          Journal:  Altern Med Rev        ISSN: 1089-5159


  20 in total

Review 1.  Oral oncoprevention by phytochemicals - a systematic review disclosing the therapeutic dilemma.

Authors:  Sujana Mulk Bhavana; Chintamaneni Raja Lakshmi
Journal:  Adv Pharm Bull       Date:  2014-08-25

2.  Modified apple polysaccharide prevents against tumorigenesis in a mouse model of colitis-associated colon cancer: role of galectin-3 and apoptosis in cancer prevention.

Authors:  Yuhua Li; Li Liu; Yinbo Niu; Juan Feng; Yang Sun; Xianghe Kong; Yongchun Chen; Xiaoyan Chen; Hongquan Gan; Shousong Cao; Qibing Mei
Journal:  Eur J Nutr       Date:  2011-04-24       Impact factor: 5.614

3.  Anticarcinogenic action of quercetin by downregulation of phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) via induction of p53 in hepatocellular carcinoma (HepG2) cell line.

Authors:  Akhilendra Kumar Maurya; Manjula Vinayak
Journal:  Mol Biol Rep       Date:  2015-08-27       Impact factor: 2.316

4.  Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization.

Authors:  Alexander V Ljubimov; Sergio Caballero; Annette M Aoki; Lorenzo A Pinna; Maria B Grant; Raquel Castellon
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-12       Impact factor: 4.799

5.  Safety and whole-body antioxidant potential of a novel anthocyanin-rich formulation of edible berries.

Authors:  Debasis Bagchi; Sashwati Roy; Viren Patel; Guanglong He; Savita Khanna; Navdeep Ojha; Christina Phillips; Sumona Ghosh; Manashi Bagchi; Chandan K Sen
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

Review 6.  Concepts and advances in cancer therapeutic vulnerabilities in RAS membrane targeting.

Authors:  James V Michael; Lawrence E Goldfinger
Journal:  Semin Cancer Biol       Date:  2017-12-02       Impact factor: 15.707

Review 7.  Pectin matrix as oral drug delivery vehicle for colon cancer treatment.

Authors:  Tin Wui Wong; Gaia Colombo; Fabio Sonvico
Journal:  AAPS PharmSciTech       Date:  2010-12-31       Impact factor: 3.246

Review 8.  Immunomodulatory dietary polysaccharides: a systematic review of the literature.

Authors:  Jane E Ramberg; Erika D Nelson; Robert A Sinnott
Journal:  Nutr J       Date:  2010-11-18       Impact factor: 3.271

Review 9.  Molecular mechanisms of action of quercetin in cancer: recent advances.

Authors:  Dharambir Kashyap; Sonam Mittal; Katrin Sak; Paavan Singhal; Hardeep Singh Tuli
Journal:  Tumour Biol       Date:  2016-07-22

Review 10.  The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations.

Authors:  Jessica L Geiger; Jennifer R Grandis; Julie E Bauman
Journal:  Oral Oncol       Date:  2015-12-28       Impact factor: 5.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.